Background: The prognostic value of amino terminal pro-brain natriuretic peptide levels in patients with acute exacerbation of chronic obstructive pulmonary disease has not been fully established. Aims: To investigate the predictive value of amino terminal pro-brain natriuretic peptide levels in terms of mortality, need for noninvasive mechanical ventilation, invasive mechanical ventilation, and weaning success. Study Design: Cohort study. Methods: Patients who were admitted to intensive care unit between December 2015 and December 2016 due to acute exacerbation of chronic obstructive pulmonary disease were included in the study. Demographic data, noninvasive mechanical ventilation application, need for invasive mechanical ventilation, a...
International audienceAIMS: To assess the clinical performance of pro-B-type natriuretic peptide 1-1...
BACKGROUND: In patients with COPD, prognosis might be determined at least in part by the extent of c...
Natriuretic peptides (NPs) are a family of prognostic biomarkers in patients with heart failure (HF)...
Background and objective: Correct and early risk stratification for critically ill pneumonia patient...
Introduction: Early detection of pulmonary hypertension or cor pulmonale could be beneficial in mana...
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) with comorbidities andcardiovascular dise...
Objective: To evaluate the utility of serial measurements of plasma N-terminal pro-brain natriureti...
Objective: Pneumonia is a leading cause of mortality worldwide, especially in theelderly. The use of...
Introduction: COPD is a common preventable disease characterized by airflow limitation that is not c...
Background: Plasma levels of brain natriuretic peptide (BNP) correlate closely with the pressure and...
Objectives. The mortality rate of patients with acute respiratory distress syndrome (ARDS) is high. ...
Natriuretic peptides are biomarkers of myocardial stress and are frequently elevated among patients ...
Introduction : The aim of this study is to compare the prognostic value of N-terminal pro-brain natr...
PURPOSE: The purpose of the study was to evaluate the utility of N-terminal pro-brain natriuretic pe...
Introduction: Congestive heart failure (CHF) is a common disease and its prevalence is increasingin ...
International audienceAIMS: To assess the clinical performance of pro-B-type natriuretic peptide 1-1...
BACKGROUND: In patients with COPD, prognosis might be determined at least in part by the extent of c...
Natriuretic peptides (NPs) are a family of prognostic biomarkers in patients with heart failure (HF)...
Background and objective: Correct and early risk stratification for critically ill pneumonia patient...
Introduction: Early detection of pulmonary hypertension or cor pulmonale could be beneficial in mana...
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) with comorbidities andcardiovascular dise...
Objective: To evaluate the utility of serial measurements of plasma N-terminal pro-brain natriureti...
Objective: Pneumonia is a leading cause of mortality worldwide, especially in theelderly. The use of...
Introduction: COPD is a common preventable disease characterized by airflow limitation that is not c...
Background: Plasma levels of brain natriuretic peptide (BNP) correlate closely with the pressure and...
Objectives. The mortality rate of patients with acute respiratory distress syndrome (ARDS) is high. ...
Natriuretic peptides are biomarkers of myocardial stress and are frequently elevated among patients ...
Introduction : The aim of this study is to compare the prognostic value of N-terminal pro-brain natr...
PURPOSE: The purpose of the study was to evaluate the utility of N-terminal pro-brain natriuretic pe...
Introduction: Congestive heart failure (CHF) is a common disease and its prevalence is increasingin ...
International audienceAIMS: To assess the clinical performance of pro-B-type natriuretic peptide 1-1...
BACKGROUND: In patients with COPD, prognosis might be determined at least in part by the extent of c...
Natriuretic peptides (NPs) are a family of prognostic biomarkers in patients with heart failure (HF)...